China
· Delayed Price · Currency is CNY Winner Medical Statistics
Total Valuation
Winner Medical has a market cap or net worth of CNY 25.15 billion. The enterprise value is 24.87 billion.
| Market Cap | 25.15B |
| Enterprise Value | 24.87B |
Important Dates
The next estimated earnings date is Monday, August 18, 2025.
| Earnings Date | Aug 18, 2025 |
| Ex-Dividend Date | May 30, 2025 |
Share Statistics
Winner Medical has 582.33 million shares outstanding. The number of shares has decreased by -1.75% in one year.
| Current Share Class | 582.33M |
| Shares Outstanding | 582.33M |
| Shares Change (YoY) | -1.75% |
| Shares Change (QoQ) | -2.22% |
| Owned by Insiders (%) | 69.86% |
| Owned by Institutions (%) | 7.85% |
| Float | 142.48M |
Valuation Ratios
The trailing PE ratio is 32.99 and the forward PE ratio is 23.64.
| PE Ratio | 32.99 |
| Forward PE | 23.64 |
| PS Ratio | 2.60 |
| PB Ratio | 2.07 |
| P/TBV Ratio | 2.77 |
| P/FCF Ratio | 55.66 |
| P/OCF Ratio | 20.97 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.17, with an EV/FCF ratio of 55.05.
| EV / Earnings | 32.65 |
| EV / Sales | 2.57 |
| EV / EBITDA | 16.17 |
| EV / EBIT | 25.96 |
| EV / FCF | 55.05 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.70 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.64 |
| Debt / FCF | 5.58 |
| Interest Coverage | 16.20 |
Financial Efficiency
Return on equity (ROE) is 6.66% and return on invested capital (ROIC) is 4.17%.
| Return on Equity (ROE) | 6.66% |
| Return on Assets (ROA) | 3.49% |
| Return on Invested Capital (ROIC) | 4.17% |
| Return on Capital Employed (ROCE) | 7.17% |
| Revenue Per Employee | 618,473 |
| Profits Per Employee | 48,684 |
| Employee Count | 15,642 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 3.06 |
Taxes
In the past 12 months, Winner Medical has paid 209.93 million in taxes.
| Income Tax | 209.93M |
| Effective Tax Rate | 20.60% |
Stock Price Statistics
The stock price has increased by +54.61% in the last 52 weeks. The beta is 0.43, so Winner Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +54.61% |
| 50-Day Moving Average | 47.75 |
| 200-Day Moving Average | 39.06 |
| Relative Strength Index (RSI) | 27.97 |
| Average Volume (20 Days) | 7,343,269 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Winner Medical had revenue of CNY 9.67 billion and earned 761.52 million in profits. Earnings per share was 1.31.
| Revenue | 9.67B |
| Gross Profit | 4.45B |
| Operating Income | 957.99M |
| Pretax Income | 1.02B |
| Net Income | 761.52M |
| EBITDA | 1.32B |
| EBIT | 957.99M |
| Earnings Per Share (EPS) | 1.31 |
Balance Sheet
The company has 3.53 billion in cash and 2.52 billion in debt, giving a net cash position of 1.01 billion or 1.74 per share.
| Cash & Cash Equivalents | 3.53B |
| Total Debt | 2.52B |
| Net Cash | 1.01B |
| Net Cash Per Share | 1.74 |
| Equity (Book Value) | 12.15B |
| Book Value Per Share | 19.74 |
| Working Capital | 3.07B |
Cash Flow
In the last 12 months, operating cash flow was 1.20 billion and capital expenditures -747.16 million, giving a free cash flow of 451.73 million.
| Operating Cash Flow | 1.20B |
| Capital Expenditures | -747.16M |
| Free Cash Flow | 451.73M |
| FCF Per Share | 0.78 |
Margins
Gross margin is 46.02%, with operating and profit margins of 9.90% and 7.87%.
| Gross Margin | 46.02% |
| Operating Margin | 9.90% |
| Pretax Margin | 10.53% |
| Profit Margin | 7.87% |
| EBITDA Margin | 13.61% |
| EBIT Margin | 9.90% |
| FCF Margin | 4.67% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.14%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 1.14% |
| Dividend Growth (YoY) | 30.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 61.98% |
| Buyback Yield | 1.75% |
| Shareholder Yield | 3.01% |
| Earnings Yield | 3.03% |
| FCF Yield | 1.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 2, 2023. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 2, 2023 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Winner Medical has an Altman Z-Score of 3.54 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.54 |
| Piotroski F-Score | 7 |